13F-HR filed by Affinity Asset Advisors, LLC
Affinity Asset Advisors, LLC filed this 13F-HR for the quarter ended 2024-09-30, filed 2024-11-13, with 86 holding rows worth $732,761,256.
- Accession
- 0001839882-24-038904
- Filer
- CIK 1773195
- Filed
- 2024-11-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2024
A holdings report, 86 entries on the cover page, a total value of $732,761,256 stated on the cover page (in dollars after the unit check, H1), rows summing to $732,761,256 with VALUE read as dollars as filed, 13F file number 028-20754. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 1,144,021 | $45,040,107 | dollars as filed | |
| FILANA THERAPEUTICS INC | 14817C107 | CMN | 1,449,300 | $42,652,899 | dollars as filed | put |
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 664,198 | $39,014,991 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 337,500 | $34,526,250 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 400,000 | $33,404,000 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 1,000,000 | $27,990,000 | dollars as filed | |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 1,400,000 | $25,228,000 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 100,000 | $21,222,000 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 400,000 | $20,440,000 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 860,399 | $19,333,166 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 435,000 | $19,227,000 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 650,000 | $18,700,500 | dollars as filed | |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 1,000,000 | $18,020,000 | dollars as filed | call |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 4,500,000 | $16,335,000 | dollars as filed | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 965,612 | $15,440,136 | dollars as filed | |
| INOZYME PHARMA INC | 45790W108 | COM | 2,822,318 | $14,760,723 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 498,420 | $14,658,532 | dollars as filed | |
| OMEROS CORP | 682143AG7 | NOTE 5.250% 2/1 | 21,525,000 | $14,636,864 | dollars as filed | principal |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 687,785 | $13,439,319 | dollars as filed | |
| COHERUS BIOSCIENCES INC | 19249HAB9 | BOND | 16,625,000 | $13,050,625 | dollars as filed | principal |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 290,447 | $12,567,642 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 525,000 | $11,943,750 | dollars as filed | |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 1,400,000 | $11,480,000 | dollars as filed | |
| KARYOPHARM THERAPEUTICS INC | 48576UAA4 | BOND | 12,250,000 | $9,616,381 | dollars as filed | principal |
| ORUKA THERAPEUTICS INC COM | 687604108 | Stock | 349,836 | $8,574,480 | dollars as filed | |
| REZOLUTE INC | 76200L309 | COMMON STOCK | 1,700,000 | $8,245,000 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 161,741 | $8,080,580 | dollars as filed | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 725,106 | $7,983,417 | dollars as filed | |
| BEONE MEDICINES LTD SPONSORED ADS | 07725L102 | ADR | 35,000 | $7,857,850 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 472,390 | $7,841,674 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 300,000 | $7,638,000 | dollars as filed | |
| CLIMB BIO INC | 28658R106 | COMMON STOCK | 1,500,000 | $7,635,000 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 80,000 | $7,189,600 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 2,499,431 | $6,823,447 | dollars as filed | |
| GERON CORP | 374163103 | COM | 1,500,000 | $6,810,000 | dollars as filed | |
| ANAPTYSBIO INC | 032724106 | COM | 200,000 | $6,700,000 | dollars as filed | put |
| PERSPECTIVE THERAPEUTICS INC | 46489V302 | COMMON STOCK | 500,000 | $6,675,000 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 225,000 | $6,414,750 | dollars as filed | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 325,000 | $6,295,250 | dollars as filed | |
| ARS PHARMACEUTICALS INC | 82835W108 | COM | 400,000 | $5,800,000 | dollars as filed | call |
| VAXCYTE INC COM | 92243G108 | Stock | 50,000 | $5,713,500 | dollars as filed | |
| ARVINAS INC | 04335A105 | COM | 225,000 | $5,541,750 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 600,000 | $5,004,000 | dollars as filed | |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 147,500 | $4,725,900 | dollars as filed | |
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 263,817 | $4,416,297 | dollars as filed | |
| TRAVERE THERAPEUTICS INC | 89422GAA5 | CNV | 5,000,000 | $4,320,000 | dollars as filed | principal |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 125,000 | $4,248,750 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 350,000 | $4,238,500 | dollars as filed | |
| NOVAVAX INC | 670002401 | COM NEW | 300,000 | $3,789,000 | dollars as filed | call |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 50,000 | $3,650,000 | dollars as filed | |
| PERCEPTIVE CAPITAL SOLUTIONS | G70077105 | CL A ORD SHS | 350,000 | $3,510,500 | dollars as filed | |
| GALECTIN THERAPEUTICS INC | 363225202 | COMMON STOCK | 1,211,400 | $3,331,350 | dollars as filed | put |
| NEXTCURE INC | 65343E108 | COM | 2,302,598 | $3,154,559 | dollars as filed | |
| SUMMIT THERAPEUTICS INC | 86627T108 | COM | 140,000 | $3,066,000 | dollars as filed | call |
| SAVARA INC | 805111101 | COM | 700,000 | $2,968,000 | dollars as filed | |
| NKARTA INC | 65487U108 | COMMON STOCK | 650,000 | $2,938,000 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 75,000 | $2,925,000 | dollars as filed | |
| IMMATICS N.V | N44445109 | SHS | 250,000 | $2,852,500 | dollars as filed | |
| SYROS PHARMACEUTICALS INC | 87184Q206 | COM NEW | 1,234,200 | $2,653,530 | dollars as filed | put |
| HELIX ACQUISITION CORP II | G4444H101 | CL A ORD SHS | 250,000 | $2,612,500 | dollars as filed | |
| CONTEXT THERAPEUTICS INC | 21077P108 | COM | 1,321,153 | $2,589,460 | dollars as filed | |
| INARI MED INC | 45332Y109 | COM | 60,000 | $2,474,400 | dollars as filed | |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 201,587 | $2,326,314 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 78,000 | $2,223,780 | dollars as filed | call |
| KEZAR LIFE SCIENCES INC | 49372L100 | COM | 2,511,778 | $1,942,107 | dollars as filed | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 300,512 | $1,893,226 | dollars as filed | |
| TECTONIC THERAPEUTIC INC | 878972108 | COMMON STOCK | 58,331 | $1,767,429 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV-27 | N62509117 | WTS | 212,974 | $1,490,818 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 25,000 | $1,262,250 | dollars as filed | |
| AEROVATE THERAPEUTICS INC | 008064107 | COM | 600,000 | $1,254,000 | dollars as filed | |
| Q32 BIO INC | 746964105 | Common Stock | 27,777 | $1,239,410 | dollars as filed | |
| VERASTEM INC | 92337C203 | COMMON STOCK | 400,000 | $1,196,000 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 15,000 | $1,054,350 | dollars as filed | |
| ZURA BIO LTD | G9TY5A101 | COMMON STOCK | 223,335 | $906,740 | dollars as filed | |
| PUMA BIOTECHNOLOGY INC | 74587V107 | COMMON STOCK | 250,000 | $637,500 | dollars as filed | |
| REPARE THERAPEUTICS INC | 760273102 | COM | 173,351 | $596,327 | dollars as filed | |
| KYVERNA THERAPEUTICS INC | 501976104 | COMMON STOCK | 119,900 | $586,311 | dollars as filed | |
| Adagio Med Hldgs Inc Com | 00534B100 | Common Stock | 213,235 | $550,146 | dollars as filed | |
| IMMATICS N.V | N44445117 | *W EXP 07/01/202 | 187,204 | $430,569 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 45,000 | $425,700 | dollars as filed | |
| VOYAGER THERAPEUTICS INC | 92915B106 | COMMON STOCK | 51,727 | $302,603 | dollars as filed | |
| METAVIA INC | 64132R404 | COM | 89,222 | $282,834 | dollars as filed | |
| GENELUX CORP | 36870H103 | COMMON STOCK | 100,000 | $237,000 | dollars as filed | |
| WHITEHAWK THERAPEUTICS INC | 00032Q104 | CMN | 47,019 | $96,859 | dollars as filed | |
| PROMIS NEUROSCIENCES INC | 74346M406 | COM NEW | 30,643 | $38,304 | dollars as filed | |
| Rocket Pharmaceuticals Inc W Exp 09/02/202 | 77313F114 | Warrant | 75,000 | $5,250 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001839882-24-038904 | this filing | 2024-11-13 | acceptance time not in the bulk data set |